Herpes zoster vaccination efficacy in the long-term care facility population: a qualitative systematic review.

Authors:
Helen Senderovich
Helen Senderovich
University of Toronto
Toronto | Canada
Jasleen Grewal
Jasleen Grewal
Simon Fraser University
Saskatoon | Canada
Maheen Mujtaba
Maheen Mujtaba
e Baycrest Health Sciences

Curr Med Res Opin 2019 Aug 23;35(8):1451-1462. Epub 2019 Apr 23.

e Baycrest Health Sciences , Toronto , Canada.

The varicella zoster virus (VZV) can reactivate later in life as herpes zoster infection (HZI), a severe disease resulting in painful complications such as post-herpetic neuralgia (PHN). The herpes zoster (HZ) vaccine has been indicated for use among adults 50 years and older for prevention of HZI. Currently, no clinical practice guideline or funding exists specifically for HZ immunization in long-term care facilities (LTCF) for adults age >60 years. This review summarizes the current literature available on the efficacy of HZ vaccine in adults over 60 years old residing in LTCF and evaluates the cost-effectiveness of the HZ vaccine. We conducted a literature search in PsycInFO, Embase and MEDLINE databases, and a grey literature search. The search was limited to the last 5 years (January 2013-April 2018). Studies that assessed the efficacy of the HZ vaccine in individuals 60 years old or older and met inclusion criteria were included. A total of 423 studies were found: 10 studies met inclusion criteria and were deemed relevant to the objectives. All reviewed studies highlighted the efficacy of the HZ vaccine for the LTCF population. The studies reviewed showed the efficacy of the HZ vaccine in relevant elderly populations residing either in LTCF or in the community including those of advanced age with multiple comorbidities. Consideration can be given to the use of the HZ vaccine for individuals over 60 in LTCF, as well as in the community.

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/03007995.2019.1
Publisher Site
http://dx.doi.org/10.1080/03007995.2019.1600482DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
August 2019
16 Reads

Publication Analysis

Top Keywords

efficacy vaccine
16
herpes zoster
12
vaccine individuals
8
literature search
8
met inclusion
8
inclusion criteria
8
long-term care
8
residing ltcf
8
vaccine
7
studies
5
ltcf
5
efficacy
5
adults age
4
included total
4
facilities ltcf
4
ltcf adults
4
criteria included
4
age >60
4
review summarizes
4
years review
4

References

(Supplied by CrossRef)
Article in Morb Mortal Wkly Rep
Harpaz R et al.
Morb Mortal Wkly Rep 2008
Article in Acad Emer Med
Kowalsky DS et al.
Acad Emer Med 2018

Similar Publications